EASL 2016: HCV Therapy Improves Quality of Life for People Who Inject Drugs, Reinfection Risk Remains
- Details
- Category: People Who Inject Drugs
- Published on Wednesday, 27 April 2016 00:00
- Written by Liz Highleyman
People on opiate substitution therapy can be successfully treated with grazoprevir/elbasvir (Zepatier), leading to improvements in some aspects of quality of life, according to findings from the C-EDGE CO-STAR study presented at the European Association for the Study of the Liver's International Liver Congress (EASL 2016) this month in Barcelona. However, the same study saw several cases of hepatitis C virus (HCV) reinfection after a cure, suggesting a greater emphasis on prevention may be warranted.
Coverage of 4th International Symposium on Hepatitis Care in Substance Users (INHSU 2015)
- Details
- Category: People Who Inject Drugs
- Published on Friday, 16 October 2015 00:00
- Written by HIVandHepatitis.com
Hepatitis C treatment for people who inject drugs, including those receiving opioid substitution therapy (OST), was a major theme of the 4th International Symposium on Hepatitis Care in Substance Users (INHSU 2015), October 7-9 in Sydney.
INHSU 2015 Highlights Hepatitis C Prevention and Treatment for People Who Inject Drugs
INHSU 2015: HCV Treatment Works Well for People Who Inject Drugs, but Barriers to Access Remain
10/16/15
INHSU 2015: HCV Treatment Works Well for People Who Inject Drugs, but Barriers to Access Remain
- Details
- Category: People Who Inject Drugs
- Published on Monday, 12 October 2015 00:00
- Written by Liz Highleyman
Hepatitis C treatment for people who inject drugs, including those receiving opioid substitution therapy (OST), was a major theme of the 4th International Symposium on Hepatitis Care in Substance Users (INHSU 2015) last week in Sydney. Studies show that treatment using new interferon-free regimens can be highly effective for this population, but barriers including high drug costs and stigma against drug users have hindered widespread access to therapy.
Web Design and Development by